|
Platinum based chemotherapy Clinical Trials
11 actively recruiting trials across 5 locations
Also known as: Cisplatin, pemetrexed, gemcitabine, carboplatin, paclitaxel, docetaxel, Standard of Care, albuminotaxol, carboplatin, cisplatin +4 more
Pipeline
Phase 2: 5Phase 3: 3Phase 1/2: 1
Top Sponsors
- Regeneron Pharmaceuticals2
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
- Zeng Jian1
- Weill Medical College of Cornell University1
- The First Affiliated Hospital of Guangzhou Medical University1
Indications
- Cancer11
- Lung Cancer9
- Non Small Cell Lung Cancer4
- Chemoradiation2
- Targeted Therapy2
Other6 trials
Birmingham, Alabama1 trial
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Central Alabama Research
Phase 3
Los Angeles, California1 trial
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Valkyrie Clinical Trials
Phase 1/2
Orange, California1 trial
Miami, Florida1 trial
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
BAPTIST ALLIANCE - MCI (Data Collection Only)
Phase 2
New York, New York1 trial
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Weill Cornell Medicine
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.